Inventor · disambiguated record
Stephen J. Klaus
Also filed as: KLAUS STEPHEN · KLAUS STEPHEN J · KLAUS STEPHEN JOSEPH
28 granted patents·31 pending applications·309 citations·filing 1998–2023
97Inventor score
Files withFIBROGEN INC29KLAUS STEPHEN J9CELL THERAPEUTICS INC7MASTERCARD INTERNATIONAL INC3SPONG SUZANNE M3
Top patents by PatentIndex Score
59 records- 0195US10626090B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2017·Granted Apr 21, 2020·6 cites·10 claims
- 0295US6878715B1Therapeutic compounds for inhibiting interleukin-12 signals and method for using sameCELL THERAPEUTICS INC·Filed 2000·Granted Apr 12, 2005·46 cites·6 claims
- 0393US10927081B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2018·Granted Feb 23, 2021·3 cites·46 claims
- 0493US10894774B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2017·Granted Jan 19, 2021·3 cites·23 claims
- 0593US10882827B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2018·Granted Jan 5, 2021·3 cites·24 claims
- 0692US9920011B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2013·Granted Mar 20, 2018·10 cites·6 claims
- 0792US8530404B2Compounds and methods for treatment of cancerSEELEY TODD W·Filed 2006·Granted Sep 10, 2013·30 cites·12 claims
- 0891US8629131B2Enhanced erythropoiesis and iron metabolismKLAUS STEPHEN J·Filed 2010·Granted Jan 14, 2014·10 cites·11 claims
- 0991US8609646B2Enhanced erythropoiesis and iron metabolismKLAUS STEPHEN J·Filed 2010·Granted Dec 17, 2013·10 cites·9 claims
- 1091US8604012B2Enhanced erythropoiesis and iron metabolismKLAUS STEPHEN J·Filed 2010·Granted Dec 10, 2013·10 cites·11 claims
- 1191US8318703B2Methods for improving kidney functionKLAUS STEPHEN J·Filed 2006·Granted Nov 27, 2012·21 cites·10 claims
- 1291US7713986B2Compounds and methods for treatment of chemotherapy-induced anemiaFIBROGEN INC·Filed 2006·Granted May 11, 2010·17 cites·8 claims
- 1389US11680048B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2020·Granted Jun 20, 2023·1 cites·14 claims
- 1489US11680047B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2020·Granted Jun 20, 2023·1 cites·23 claims
- 1589US8124582B2Treatment of diabetesGUENZLER-PUKALL VOLKMAR·Filed 2003·Granted Feb 28, 2012·38 cites·15 claims
- 1689US7618940B2Fat regulationFIBROGEN INC·Filed 2003·Granted Nov 17, 2009·35 cites·16 claims
- 1788US8604013B2Enhanced erythropoiesis and iron metabolismKLAUS STEPHEN J·Filed 2010·Granted Dec 10, 2013·6 cites·13 claims
- 1887US2024182424A1Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2023·Application pending·0 cites
- 1983US8614204B2Enhanced erythropoiesis and iron metabolismKLAUS STEPHEN J·Filed 2004·Granted Dec 24, 2013·8 cites·13 claims
- 2079US6469017B1Method of inhibiting interleukin-12 signalingCELL THERAPEUTICS INC·Filed 1998·Granted Oct 22, 2002·17 cites·11 claims
- 2179US2021369702A1Methods for treating anemia in subjects having kidney failure using inhibitors of hypoxia-inducible factor (hif) hydroxylaseFIBROGEN INC·Filed 2021·Application pending·0 cites
- 2275US8865173B2Treatments for pancreatic cancer metastasesSPONG SUZANNE M·Filed 2008·Granted Oct 21, 2014·1 cites·3 claims
- 2367US2017216274A1Enhanced Erythropoiesis and Iron MetabolismFIBROGEN INC·Filed 2017·Application pending·0 cites
- 2467US2015080425A1Methods for treating anemia in subjects having kidney failure using inhibitors of hypoxia-inducible factor (hif) hydroxylaseKLAUS STEPHEN J·Filed 2014·Application pending·0 cites
- 2567US2017216248A1Enhanced Erythropoiesis and Iron MetabolismFIBROGEN INC·Filed 2017·Application pending·0 cites
- 2666US6774130B2Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using sameCELL THERAPEUTICS INC·Filed 1999·Granted Aug 10, 2004·22 cites·26 claims
- 2766US6693105B1Hydroxyl-containing compoundsCELL THERAPEUTICS INC·Filed 1999·Granted Feb 17, 2004·11 cites·18 claims
- 2865US2017312268A1Methods for treating a neurological disorder in a subject using inhibitors of hypoxia-inducible factor (hif) proyl hydroxylaseFIBROGEN INC·Filed 2017·Application pending·0 cites
- 2963US2013203805A1Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylaseKLAUS STEPHEN J·Filed 2012·Application pending·0 cites
- 3063US2007293575A1Compounds and methods for treatment of cancer-related anemiaFIBROGEN INC·Filed 2006·Application pending·0 cites
- 3163US2006276477A1Treatment method for anemiaFIBROGEN INC·Filed 2006·Application pending·0 cites
- 3261US2006178317A1Methods of increasing endogenous erythropoietin (EPO)FIBROGEN INC·Filed 2006·Application pending·0 cites
- 3361US2006183695A1Methods of increasing endogenous erythropoietin (EPO)FIBROGEN INC·Filed 2006·Application pending·0 cites
- 3461US2006178316A1Methods of increasing endogenous erythropoietin (EPO)FIBROGEN INC·Filed 2006·Application pending·0 cites
- 3560US12288210B2Systems and methods for account processing validationMASTERCARD INTERNATIONAL INC·Filed 2019·Granted Apr 29, 2025·0 cites·20 claims
- 3660US10325258B2Systems and methods for account processing validationMASTERCARD INTERNATIONAL INC·Filed 2014·Granted Jun 18, 2019·0 cites·23 claims
- 3760US2011166178A1Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylaseFIBROGEN INC·Filed 2011·Application pending·0 cites
- 3859US2011039885A1Methods for increasing endothelial progenitor cellsFIBROGEN INC·Filed 2008·Application pending·0 cites
- 3958US8202834B2Fat regulationFOURNEY PATRICK D·Filed 2009·Granted Jun 19, 2012·0 cites·27 claims
- 4055US8728468B2Treatments for cancerSPONG SUZANNE M·Filed 2012·Granted May 20, 2014·0 cites·3 claims
- 4155US2006251638A1Cytoprotection through the use of hif hydroxylase inhibitorsGUENZLER-PUKALL VOLKMAR·Filed 2004·Application pending·0 cites
- 4255US2003153503A1Methods of increasing endogenous erythropoietin (EPO)Filed 2002·Application pending·0 cites
- 4354US2005271670A1Treatments for cancerSPONG SUZANNE M·Filed 2005·Application pending·0 cites
- 4454US2005032748A1Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using sameCELL THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 4554US2010331362A1Treatment method for anemiaFIBROGEN INC·Filed 2010·Application pending·0 cites
- 4653US9922311B2Account mask identifier apparatus, method, and computer program productMASTERCARD INTERNATIONAL INC·Filed 2014·Granted Mar 20, 2018·0 cites·18 claims
- 4753US2010144737A1Methods for inhibiting t helper cell differentiationFIBROGEN INC·Filed 2008·Application pending·0 cites
- 4852US2011263642A1Methods for treatment of multiple sclerosisFIBROGEN INC·Filed 2009·Application pending·0 cites
- 4952US2003207901A1Hydroxyl-containing compoundsCELL THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 5051US2005049262A1Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using sameCELL THERAPEUTICS INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen J. Klaus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →